CML is driven by the bcr–abl fusion gene generated from the t(9;22)(q34;q11) translocation, resulting in a derivative, 22q-, traditionally known as the Philadelphia chromosome [2]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.